These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9394769)

  • 1. Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines.
    Lee J; O'Morain C
    Gastroenterology; 1997 Dec; 113(6 Suppl):S99-106. PubMed ID: 9394769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
    Nakajima S; Graham DY; Hattori T; Bamba T
    Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
    Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
    Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
    Kodama M; Murakami K; Okimoto T; Fujioka T
    Nihon Rinsho; 2008 Apr; 66(4):804-10. PubMed ID: 18409534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
    Gut; 1997 Jul; 41(1):8-13. PubMed ID: 9274464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key points from the revised Maastricht Consensus Report: the impact on general practice.
    Bazzoli F
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.
    Lam SK; Talley NJ
    J Gastroenterol Hepatol; 1998 Jan; 13(1):1-12. PubMed ID: 9737564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to Helicobacter pylori infection in children.
    Gold BD
    Curr Gastroenterol Rep; 2001 Jun; 3(3):235-47. PubMed ID: 11353561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease.
    Lee J; O'Morain C
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):527-31. PubMed ID: 9187889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research.
    Satoh K
    J Gastroenterol; 2002; 37 Suppl 13():34-8. PubMed ID: 12109663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
    Vasapolli R; Malfertheiner P; Kandulski A
    Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP; Pajares JM; Losa C
    Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication of H. pylori eradication therapy].
    Ohtaka K; Miwa H; Sato N
    Nihon Rinsho; 2003 Jan; 61(1):97-101. PubMed ID: 12607324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.